Cargando…

Immunotherapy in NSCLC Patients with Brain Metastases

Approximately 40% of unselected non-small cell lung cancer (NSCLC) patients develop brain metastases (BMs) during their disease, with considerable morbidity and mortality. The management of BMs in patients with NSCLC is a clinical challenge and requires a multidisciplinary approach to gain effective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buriolla, Silvia, Pelizzari, Giacomo, Corvaja, Carla, Alberti, Martina, Targato, Giada, Bortolot, Martina, Torresan, Sara, Cortiula, Francesco, Fasola, Gianpiero, Follador, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267075/ https://www.ncbi.nlm.nih.gov/pubmed/35806080 http://dx.doi.org/10.3390/ijms23137068

Ejemplares similares

Non-small cell lung cancer harboring EGFR G724S mutation and exon 19 deletion responded to afatinib monotherapy after multiple lines of target therapies
por: Cortiula, Francesco, et al.
Publicado: (2022)

Radiation Recall Pneumonitis Anticipates Bilateral Immune-Induced Pneumonitis in Non-Small Cell Lung Cancer
por: Torresan, Sara, et al.
Publicado: (2023)

First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study
por: Basile, Debora, et al.
Publicado: (2021)

CDK4/6 Inhibitors in Melanoma: A Comprehensive Review
por: Garutti, Mattia, et al.
Publicado: (2021)

Feasibility and Predictive Performance of a Triage System for Patients with Cancer During the COVID‐19 Pandemic
por: Fasola, Gianpiero, et al.
Publicado: (2021)

A Multi-Center, Real-Life Experience on Liquid Biopsy Practice for EGFR Testing in Non-Small Cell Lung Cancer (NSCLC) Patients
por: Cortiula, Francesco, et al.
Publicado: (2020)

CDK4/6 Inhibitors as Upfront Treatment in a Patient with Breast Cancer Presenting with a Clinical Critic Situation: A Case Report and Review of the Literature
por: Targato, Giada, et al.
Publicado: (2022)

1741P Triage procedures for COVID-19 in an Italian cancer centre
por: Targato, G., et al.
Publicado: (2020)

Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer
por: Gerratana, Lorenzo, et al.
Publicado: (2020)

1626P The perks of SARS-CoV-2 monitoring through serial nasopharyngeal (NP) swabs in an Italian high prevalence area
por: Bortot, L., et al.
Publicado: (2021)

Fulminating septic shock from Clostridium perfringens in an early breast cancer patient with severe myalgia after docetaxel treatment
por: Minisini, Alessandro Marco, et al.
Publicado: (2011)

Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report
por: Fasola, Gianpiero, et al.
Publicado: (2006)

Drug waste minimization as an effective strategy of cost-containment in Oncology
por: Fasola, Gianpiero, et al.
Publicado: (2014)

Multidisciplinary Approach to Patients With Metastatic Spinal Cord Compression: A Diagnostic Therapeutic Algorithm to Improve the Neurological Outcome
por: Rispoli, Rossella, et al.
Publicado: (2022)

Immunotherapy in NSCLC Patients With Brain and Leptomeningeal Metastases
por: Pierret, Thomas, et al.
Publicado: (2022)

The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer
por: Lisanti, Camilla, et al.
Publicado: (2022)

Detection of SARS-CoV-2 infection prevalence in 860 cancer patients with a combined screening procedure including triage, molecular nasopharyngeal swabs and rapid serological test. A report from the first epidemic wave
por: Candoni, Anna, et al.
Publicado: (2022)

Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example
por: Gerratana, Lorenzo, et al.
Publicado: (2016)

Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer
por: Garattini, Silvio Ken, et al.
Publicado: (2021)

Assessment of the Mutational Status of NSCLC Using Hypermetabolic Circulating Tumor Cells
por: Turetta, Matteo, et al.
Publicado: (2018)

Drug waste minimisation and cost-containment in Medical Oncology: Two-year results of a feasibility study
por: Fasola, Gianpiero, et al.
Publicado: (2008)

Find the Flame: Predictive Biomarkers for Immunotherapy in Melanoma
por: Garutti, Mattia, et al.
Publicado: (2021)

Statins and immunotherapy: Togetherness makes strength The potential effect of statins on immunotherapy for NSCLC
por: Rossi, Alessandro, et al.
Publicado: (2021)

New Generations of Tyrosine Kinase Inhibitors in Treating NSCLC with Oncogene Addiction: Strengths and Limitations
por: Attili, Ilaria, et al.
Publicado: (2023)

The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients
por: Basile, Debora, et al.
Publicado: (2019)

Multidisciplinary Team Meeting Proposal and Final Therapeutic Choice in Early Breast Cancer: Is There an Agreement?
por: Bortot, Lucia, et al.
Publicado: (2022)

EGFR T790M testing through repeated liquid biopsy over time: a real-world multicentric retrospective experience
por: Dal Maso, Alessandro, et al.
Publicado: (2022)

Implementation of Precision Oncology in Clinical Practice: Results of a National Survey for Health Care Professionals
por: Fasola, Gianpiero, et al.
Publicado: (2023)

Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for a Cost-Effective and Dynamic Biomarker
por: Pelizzari, Giacomo, et al.
Publicado: (2019)

NSCLC Biomarkers to Predict Response to Immunotherapy with Checkpoint Inhibitors (ICI): From the Cells to In Vivo Images
por: Liberini, Virginia, et al.
Publicado: (2021)

Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives
por: Lazzari, Chiara, et al.
Publicado: (2023)

From Whole-Brain Radiotherapy to Immunotherapy: A Multidisciplinary Approach for Patients with Brain Metastases from NSCLC
por: Protopapa, Maria, et al.
Publicado: (2019)

The Landscape of Immunotherapy Resistance in NSCLC
por: Frisone, Daniele, et al.
Publicado: (2022)

EGFR-Driven Mutation in Non-Small-Cell Lung Cancer (NSCLC) Influences the Features and Outcome of Brain Metastases
por: Armocida, Daniele, et al.
Publicado: (2023)

Management of patients with brain metastases from NSCLC without a genetic driver alteration: upfront radiotherapy or immunotherapy?
por: Merkin, Ross D., et al.
Publicado: (2023)

First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study
por: Lorenzi, Martina, et al.
Publicado: (2021)

MET in Non-Small-Cell Lung Cancer (NSCLC): Cross ‘a Long and Winding Road’ Looking for a Target
por: Spitaleri, Gianluca, et al.
Publicado: (2023)

Recent Advances in Immunotherapy in Metastatic NSCLC
por: Bansal, Pranshu, et al.
Publicado: (2016)

Immunotherapy and NSCLC: The Long and Winding Road
por: Rossi, Antonio
Publicado: (2020)

Cryobiopsy for pneumonitis diagnosis in NSCLC immunotherapy
por: Zarogoulidis, Paul, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6njgmsqmbj79m6iiavaks7auo7